Dr. Joshua Dearborn joined the Department of Medicine in the Division of Oncology as an Instructor on June 1, 2019.
Dr. Dearborn is a behavioral neuroscientist with training in molecular biology. His research interests revolve around the neurobiology and etiology of neurodevelopmental disorders. He has a strong background in the application of rodent models in behavioral assays to investigate the neurobiological mechanisms related to behavioral disruptions observed in psychiatric disorders. Dr. Dearborn is interested in determining the underlying mechanisms leading to the CNS defects associated with lysosomal storage diseases and using that information to develop effective therapies for this class of disease. Currently, he is inspired by the lack of clear understanding of the molecular- and circuit-level neuropathology mediating the symptoms of neurodevelopmental disorders such as infantile neuronal ceroid lipofuscinosis.